|
|
|
|
LEADER |
02344nam a2200373 u 4500 |
001 |
EB001999712 |
003 |
EBX01000000000000001162613 |
005 |
00000000000000.0 |
007 |
tu||||||||||||||||||||| |
008 |
210907 r ||| eng |
020 |
|
|
|a 0309675332
|
020 |
|
|
|a 9780309675338
|
100 |
1 |
|
|a Amponsah, Edith
|
245 |
0 |
0 |
|a Exploring the frontiers of innovation to tackle microbial threats
|h Elektronische Ressource
|b proceedings of a workshop
|c Edith Amponsah, Gillian Buckley, Julie Pavlin, and Anna Nicholson, rapporteurs ; Forum on Microbial Threats, Board on Global Health, Health and Medicine Division, The National Academies of Sciences, Engineering, Medicine
|
260 |
|
|
|a Washington, DC
|b The National Academies Press
|c [2020], 2020
|
300 |
|
|
|a 1 PDF file (xx, 158 pages)
|b illustrations
|
505 |
0 |
|
|a Includes bibliographical references
|
653 |
|
|
|a Inventions
|
653 |
|
|
|a Bacterial Infections / prevention & control
|
653 |
|
|
|a Anti-Infective Agents / immunology
|
653 |
|
|
|a Anti-Infective Agents / therapeutic use
|
653 |
|
|
|a Drug Discovery
|
653 |
|
|
|a Drug Resistance, Microbial / immunology
|
653 |
|
|
|a Bacterial Infections / diagnosis
|
700 |
1 |
|
|a Buckley, Gillian J.
|e [rapporteur]
|
700 |
1 |
|
|a Pavlin, Julie
|e [rapporteur]
|
700 |
1 |
|
|a Nicholson, Anna
|e [rapporteur]
|
710 |
2 |
|
|a National Academies of Sciences, Engineering, and Medicine (U.S.)
|b Forum on Microbial Threats
|
710 |
2 |
|
|a Exploring the Frontiers of Innovation to Tackle Microbial Threats (Workshop) (2019, Washington, D.C.)
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
856 |
4 |
0 |
|u http://www.ncbi.nlm.nih.gov/books/NBK560433
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
082 |
0 |
|
|a 610
|
520 |
|
|
|a On December 4-5, 2019, the National Academies of Sciences, Engineering, and Medicine held a 1.5-day public workshop titled Exploring the Frontiers of Innovation to Tackle Microbial Threats. The workshop participants examined major advances in scientific, technological, and social innovations against microbial threats. Such innovations include diagnostics, vaccines (both development and production), and antimicrobials, as well as nonpharmaceutical interventions and changes in surveillance. This publication summarizes the presentations and discussions from the workshop
|